{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:59Z","timestamp":1786982519975,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2021KY580"],"award-info":[{"award-number":["2021KY580"]}]},{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2021KY580"],"award-info":[{"award-number":["2021KY580"]}]},{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2021KY580"],"award-info":[{"award-number":["2021KY580"]}]},{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2021KY580"],"award-info":[{"award-number":["2021KY580"]}]},{"name":"Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission","award":["2021KY580"],"award-info":[{"award-number":["2021KY580"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03191-x","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:03:19Z","timestamp":1752667399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors and prognostic analysis of endometrial cancer with para-aortic lymph node metastasis"],"prefix":"10.1007","volume":"16","author":[{"given":"Feng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"4","key":"3191_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978\u20132013. J Natl Cancer Inst. 2018;110(4):354\u201361.","journal-title":"J Natl Cancer Inst"},{"key":"3191_CR2","doi-asserted-by":"crossref","unstructured":"Markowska A, Chudecka-Glaz A, Pitynski K, Baranowski W, Markowska J, Sawicki W. Endometrial cancer management in young women. Cancers (Basel). 2022;14(8).","DOI":"10.3390\/cancers14081922"},{"issue":"8","key":"3191_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body fatness and cancer\u2013viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"3191_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.7150\/jca.104214","volume":"16","author":"H Zheng","year":"2025","unstructured":"Zheng H, Yu C, Yang L, Zhou F, Liu A. Research progress of DNA methylation markers for endometrial carcinoma diagnosis. J Cancer. 2025;16(3):812\u201320.","journal-title":"J Cancer"},{"issue":"1","key":"3191_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jjco\/hyad135","volume":"54","author":"Y Ueno","year":"2024","unstructured":"Ueno Y, Yoshida E, Nojiri S, Kato T, Ohtsu T, Takeshita T, et al. Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer. Jpn J Clin Oncol. 2024;54(1):38\u201346.","journal-title":"Jpn J Clin Oncol"},{"issue":"10023","key":"3191_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094\u2013108.","journal-title":"Lancet"},{"issue":"1","key":"3191_CR7","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3191_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","volume":"478","author":"N Concin","year":"2021","unstructured":"Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 2021;478(2):153\u201390.","journal-title":"Virchows Arch"},{"key":"3191_CR9","doi-asserted-by":"crossref","unstructured":"Kopatsaris S, Tsakiridis I, Kapetanios G, Zachomitros F, Michos G, Papanikolaou E, et al. Manage endometrial cancer: comp rev guidelines. Cancers (Basel). 2024;16(21).","DOI":"10.3390\/cancers16213582"},{"issue":"1","key":"3191_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S, et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):367.","journal-title":"Signal Transduct Target Ther"},{"key":"3191_CR11","doi-asserted-by":"publisher","first-page":"1490347","DOI":"10.3389\/fonc.2024.1490347","volume":"14","author":"L Han","year":"2024","unstructured":"Han L, Chen Y, Zheng A, Tan X, Chen H. Paraaortic lymph node metastasis in endometrial cancer patients: a comprehensive analysis of rates, survival outcomes, and risk factors through systematic review and meta-analysis. Front Oncol. 2024;14:1490347.","journal-title":"Front Oncol"},{"issue":"3","key":"3191_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12253-014-9893-4","volume":"21","author":"I Alay","year":"2015","unstructured":"Alay I, Turan T, Ureyen I, Karalok A, Tasci T, Ozfuttu A, et al. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer. Pathol Oncol Res. 2015;21(3):803\u201310.","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"3191_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10147-017-1139-5","volume":"22","author":"ME Sari","year":"2017","unstructured":"Sari ME, Yalcin I, Sahin H, Meydanli MM, Gungor T. Risk factors for paraaortic lymph node metastasis in endometrial cancer. Int J Clin Oncol. 2017;22(5):937\u201344.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"3191_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/13645706.2020.1868009","volume":"31","author":"G Gitas","year":"2022","unstructured":"Gitas G, Freytag D, Allahqoli L, Baum S, Rody A, Maass N, et al. Lymphadenectomy in endometrial cancer\u2014achieving more with less? Minim Invasive Ther Allied Technol. 2022;31(4):531\u20139.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"4","key":"3191_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/ijgc-2023-005134","volume":"34","author":"M Pavone","year":"2024","unstructured":"Pavone M, Jochum F, Lecointre L, Fanfani F, Scambia G, Querleu D, et al. Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2024;34(4):519\u201327.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"3191_CR16","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/09603271211008506","volume":"40","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang W, Luo Z, Huang J, Li L. Clinical study of the clinical characteristics and prognosis of 1219 cases of endometrial cancer with lymph node metastasis. Hum Exp Toxicol. 2021;40(10):1601\u201311.","journal-title":"Hum Exp Toxicol"},{"issue":"23","key":"3191_CR17","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"3\u20134","key":"3191_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000525405","volume":"87","author":"V Di Donato","year":"2022","unstructured":"Di Donato V, D\u2019Oria O, Giannini A, Bogani G, Fischetti M, Santangelo G, et al. Age-Adjusted Charlson comorbidity index predicts survival in endometrial cancer patients. Gynecol Obstet Invest. 2022;87(3\u20134):191\u20139.","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"3191_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0042-1744412","volume":"49","author":"P Ciudad","year":"2022","unstructured":"Ciudad P, Escandon JM, Manrique OJ, Bustos VP. Lessons learnt from an 11-year experience with lymphatic surgery and a systematic review of reported complications: technical considerations to reduce morbidity. Arch Plast Surg. 2022;49(2):227\u201339.","journal-title":"Arch Plast Surg"},{"issue":"6","key":"3191_CR20","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1067\/mob.2000.107335","volume":"182","author":"A Mariani","year":"2000","unstructured":"Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182(6):1506\u201319.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3191_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ygyno.2012.08.024","volume":"127","author":"S Kumar","year":"2012","unstructured":"Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012;127(3):525\u201331.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"3191_CR22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1159\/000492585","volume":"41","author":"ME Sari","year":"2018","unstructured":"Sari ME, Meydanli MM, Yalcin I, Sahin H, Coban G, Celik H, et al. Risk factors for lymph node metastasis among lymphovascular space Invasion-Positive women with endometrioid endometrial Cancer clinically confined to the uterus. Oncol Res Treat. 2018;41(12):750\u20134.","journal-title":"Oncol Res Treat"},{"issue":"3","key":"3191_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/PGP.0000000000000596","volume":"39","author":"MM Meydanli","year":"2020","unstructured":"Meydanli MM, Aslan K, Oz M, Muftuoglu KH, Yalcin I, Engin-Ustun Y. Is it possible to develop a prediction model for lymphovascular space invasion in endometrioid endometrial cancer?? Int J Gynecol Pathol. 2020;39(3):213\u201320.","journal-title":"Int J Gynecol Pathol"},{"key":"3191_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejogrb.2019.07.015","volume":"240","author":"MM Meydanli","year":"2019","unstructured":"Meydanli MM, Aslan K, Oz M, Muftuoglu KH, Yalcin I, Engin-Ustun Y. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: the lymph node metastasis risk index. Eur J Obstet Gynecol Reprod Biol. 2019;240:310\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3191_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2015.01.006","volume":"186","author":"U Solmaz","year":"2015","unstructured":"Solmaz U, Mat E, Dereli ML, Turan V, Tosun G, Dogan A, et al. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2015;186:63\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"3191_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ijgo.15937","volume":"168","author":"A Benseler","year":"2025","unstructured":"Benseler A, Vicus D, Covens A, Kupets R, Parra-Herran C, Gien LT. Assessing para-aortic nodal status in high-grade endometrial cancer patients with negative pelvic Sentinel lymph node biopsy. Int J Gynaecol Obstet. 2025;168(3):1258\u201363.","journal-title":"Int J Gynaecol Obstet"},{"key":"3191_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygyno.2024.12.010","volume":"193","author":"A Neilson","year":"2025","unstructured":"Neilson A, Jamieson A, Chiu D, Leung S, Lum A, Kommoss S, et al. Serum CA125 levels in the context of promise molecular classification provides pre-operative prognostic information that can direct endometrial cancer management. Gynecol Oncol. 2025;193:1\u201311.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3191_CR28","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.62347\/FPUJ8382","volume":"14","author":"Y Meng","year":"2024","unstructured":"Meng Y, Feng J, Yang J, Yin H. Clinicopathological characteristics of endometrial carcinoma with different molecular subtypes and their correlation with lymph node metastasis. Am J Cancer Res. 2024;14(8):3994\u20134003.","journal-title":"Am J Cancer Res"},{"key":"3191_CR29","doi-asserted-by":"publisher","first-page":"890908","DOI":"10.3389\/fonc.2022.890908","volume":"12","author":"K Njoku","year":"2022","unstructured":"Njoku K, Barr CE, Crosbie EJ. Current and emerging prognostic biomarkers in endometrial Cancer. Front Oncol. 2022;12:890908.","journal-title":"Front Oncol"},{"issue":"5","key":"3191_CR30","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3802\/jgo.2017.28.e59","volume":"28","author":"Y Todo","year":"2017","unstructured":"Todo Y, Takeshita S, Okamoto K, Yamashiro K, Kato H. Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis. J Gynecol Oncol. 2017;28(5):e59.","journal-title":"J Gynecol Oncol"},{"key":"3191_CR31","doi-asserted-by":"crossref","unstructured":"Bruchim I, Capasso I, Polonsky A, Meisel S, Salutari V, Werner H et al. New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere. Expert Opin Ther Targets 2024;28(1\u20132):29\u201343.","DOI":"10.1080\/14728222.2024.2316739"},{"key":"3191_CR32","doi-asserted-by":"crossref","unstructured":"Galant N, Krawczyk P, Monist M, Obara A, Gajek L, Grenda A et al. Molecular classification of endometrial cancer and its impact on therapy selection. Int J Mol Sci. 2024;25(11).","DOI":"10.3390\/ijms25115893"},{"key":"3191_CR33","doi-asserted-by":"crossref","unstructured":"Ronsini C, Restaino S, Paparcura F, Vizzielli G, Raffone A, Di Donna MC et al. Microsatellite instability as a risk factor for occult lymph node metastasis in early-stage endometrial cancer: a retrospective multicenter study. Cancers (Basel). 2025;17(7).","DOI":"10.3390\/cancers17071162"},{"issue":"9","key":"3191_CR34","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ccell.2023.07.007","volume":"41","author":"Y Dou","year":"2023","unstructured":"Dou Y, Katsnelson L, Gritsenko MA, Hu Y, Reva B, Hong R, et al. Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell. 2023;41(9):1586\u2013605. e15.","journal-title":"Cancer Cell"},{"issue":"2","key":"3191_CR35","doi-asserted-by":"publisher","first-page":"102155","DOI":"10.1016\/j.omtn.2024.102155","volume":"35","author":"X Liu","year":"2024","unstructured":"Liu X, Wang W, Zhang X, Liang J, Feng D, Li Y, et al. Metabolism pathway-based subtyping in endometrial cancer: an integrated study by multi-omics analysis and machine learning algorithms. Mol Ther Nucleic Acids. 2024;35(2):102155.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"3191_CR36","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1158\/2159-8290.CD-23-0546","volume":"13","author":"B Weigelt","year":"2023","unstructured":"Weigelt B, Marra A, Selenica P, Rios-Doria E, Momeni-Boroujeni A, Berger MF, et al. Molecular characterization of endometrial carcinomas in black and white patients reveals disparate drivers with therapeutic implications. Cancer Discov. 2023;13(11):2356\u201369.","journal-title":"Cancer Discov"},{"key":"3191_CR37","doi-asserted-by":"crossref","unstructured":"Cosgrove CM, Zamarin D, Conejo-Garcia JR, Hacker KE, Vargas R, Konstantinopoulos PA et al. A working group report from the 2024 NCI\/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era. J Natl Cancer Inst. 2025 Apr 11.","DOI":"10.1093\/jnci\/djaf089"},{"issue":"4","key":"3191_CR38","doi-asserted-by":"publisher","first-page":"108260","DOI":"10.1016\/j.ejso.2024.108260","volume":"50","author":"Y Sun","year":"2024","unstructured":"Sun Y, Wang Y, Cheng X, Wu W, Liu Q, Chen X, et al. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer. Eur J Surg Oncol. 2024;50(4):108260.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3191_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2018.03.046","volume":"149","author":"S Venigalla","year":"2018","unstructured":"Venigalla S, Chowdhry AK, Shalowitz DI. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers. Gynecol Oncol. 2018;149(3):531\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3191_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12885-023-11793-3","volume":"24","author":"X You","year":"2024","unstructured":"You X, Dong Y, Wang J, Cheng Y, Jia Y, Zhang X, et al. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases. BMC Cancer. 2024;24(1):99.","journal-title":"BMC Cancer"},{"issue":"6","key":"3191_CR41","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1111\/jog.12399","volume":"40","author":"S Tomisato","year":"2014","unstructured":"Tomisato S, Yamagami W, Susumu N, Kuwahata M, Takigawa A, Nomura H, et al. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer. J Obstet Gynaecol Res. 2014;40(6):1733\u20139.","journal-title":"J Obstet Gynaecol Res"},{"issue":"8","key":"3191_CR42","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/ijgc-2020-001446","volume":"30","author":"G Bogani","year":"2020","unstructured":"Bogani G, Cappuccio S, Casarin J, Narasimhulu DMM, Cilby WA, Glaser GE, et al. Role of adjuvant therapy in stage IIIC2 endometrial cancer. Int J Gynecol Cancer. 2020;30(8):1169\u201376.","journal-title":"Int J Gynecol Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03191-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:00:12Z","timestamp":1757246412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3191"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03191-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and was reviewed and approved by the Ethics Committee of Zhejiang Cancer Hospital (approval number: IRB-2023-1050). Prior to undergoing surgical treatment, all patients provided written informed consent to participate in this study. The consent process complied with both institutional requirements and international ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm that the manuscript contains no individual patient data in any form (including text, images, or identifiers). Participants were informed about the publication of aggregate findings and provided consent accordingly. The authors affirm that publication does not compromise participant confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1344"}}